Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...
Company to share updates at the AACR and ASGCT annual meetings BOSTON--(BUSINESS WIRE)--Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, ...
While mRNA-based COVID-19 vaccines are the best known application of the molecule, researchers around the world have found additional uses for mRNA technology beyond the realm of vaccines. They're ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...
mRNA, often referred to as the "blueprint of life," is a crucial molecule involved in protein synthesis. It carries genetic information from DNA, the genetic code, to the cell's protein-making ...
UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences. A new artificial intelligence model can improve the process of drug and vaccine discovery by ...
Subtle differences in an mRNA sequence enables a ribosome to produce more or less of a certain protein. A new AI model called RiboNN predicts which sequences will be most efficiently produced and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results